Short answer
ResMed (RMD) filed its Q3 2025 10-Q quarterly report on Oct 31, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $1.3B (up 9.1% year over year) with net income of $349M.
Q3 2025 key financials · XBRL
- Revenue
- $1.3B
- +9.1% YoY
- Net income
- $349M
- +11.9% YoY
- Operating margin
- 33.4%
- Gross margin
- 61.5%
- EPS (diluted)
- $2.37
- +12.3% YoY
Source: XBRL data from the ResMed (RMD) Q3 2025 10-Q on SEC EDGAR. USD.
ResMed Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No material changes to risk factors since the fiscal year 2025 10-K filing
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ResMed quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.